ITGAM and neoplasm: 3 and 4 demonstrated consistent data on changes in the level of CD11b+Ly-6G+/Ly-6C+ phagocytes (a significant decrease in CD11b+Ly-6C+), which indicated the lack of a pronounced saturation of the tumor site (recruitment to the tumor site) with peripheral cells bearing characteristic markers (Figure 1(c)).